Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecular spies illuminate drug resistance proteins

13.05.2005


Intricate details about a cellular protein, worked out by Vanderbilt University Medical Center scientists, may aid in the design of drugs that cells find ’irresistible.’



Resistance to antibiotics and chemotherapeutic agents is a growing medical concern. Multidrug resistance (MDR), in which cells are resistant to a number of unrelated drugs, is a particular problem in cancer chemotherapy. One mechanism that underlies MDR results from a normally beneficial cellular process. Multidrug transporters, proteins embedded in the membrane of every cell from the most humble bacterium to the most sophisticated human cell, provide an important, nonspecific form of protection by purging toxic compounds from the cell. "Multidrug transporters are a part of a defense mechanism universal to all organisms that allows them to remove cytotoxic molecules out of the cytoplasm," said Hassane Mchaourab, Ph.D., associate professor of Molecular Physiology and Biophysics, at Vanderbilt University Medical Center, the senior author on the study.

But, in doing so, they contribute to cells becoming resistant to some therapeutic drugs, most notably antibiotics and chemotherapy drugs. In the May 13 issue of Science, Vanderbilt University Medical Center scientists reveal details about the structure and function of a multidrug transporter called MsbA that may help advance the design of new antibiotics and chemotherapy drugs that will be able to evade these transporters.


The first step in designing drugs that can defy these proteins is determining the structure and function of these transporters. The basic structure of MsbA had previously been determined through crystal structure analysis, which provides a visual representation of an individual protein. However, a static model, which a crystal structure provides, reveals little about the way that protein functions. "Crystal structure gives you a snapshot, but what you really want is a movie," Mchaourab said. Using a sophisticated molecular espionage technique called spin labeling, Mchaourab and colleagues attempted to make that movie.

First, they isolated MsbA protein from E. coli and inserted the pure protein into liposomes, synthetic membranes that mimic the protein’s natural home in the cell membrane. Then, they sent in the spies. "The basic strategy (in spin labeling) is to introduce probes into the protein, sort of molecular spies, and then receive signals from these molecular spies and decode them to describe the local structure around them." "By moving the spy across the entire protein structure, you are able to get a picture, a reasonable, medium resolution structure of the protein. Even more important, you can watch the change in the structure during the functional cycle."

While their structure looked similar to the previous crystal structures except in functionally important details, the spies were able to reveal something the crystal structures couldn’t – the opening and closing of the transporter in response to energy expenditure. Multidrug transporters like MsbA pump molecules out of the cell using the energy released by the reaction of ATP (adenosine triphosphate), the cell’s ’fuel’ source, and water. This characteristic puts them in a special class of transporters, called ABC (ATP-binding cassette) transporters.

The researchers saw that ATP binding to the protein caused the chamber, a pore-like hole in the protein, to close from the inside of the cell outwards. This traps a molecule, like a drug or toxin, inside the chamber. At about the same time, the external part of the chamber begins to open, which allows the trapped molecule to be expelled from the cell. These findings provide an important first step towards combating drug resistance in humans and infectious organisms. Humans have 47 types of multidrug ABC transporters, the most prominent and notorious being P-glycoprotein, which is responsible for resistance to chemotherapy.

Since the MsbA protein used in this study is about 35 percent identical to the P-glycoprotein found in humans, information gained about it should also apply to transporters involved in human drug resistance. Additionally, MsbA is also the only ABC transporter in E. coli that is essential for the survival of the organism, which makes it a possible therapeutic target. "The motivation for this work is to understand where the substrate binds and how it moves across so that one can start thinking about designing inhibitors of these molecules," Mchaourab said. "Whether it’s resistance to infectious diseases or resistance to chemotherapy, the goal is to silence these proteins by designing inhibitors that bind tighter than the chemotherapeutic drugs or the antibiotics."

The research was supported by a Vanderbilt Discovery Grant. Other Vanderbilt authors on the paper were Jinhui Dong, a graduate student and first author, and Guangyong Yang, research assistant in the Mchaourab lab.

Clinton Colmenares | EurekAlert!
Further information:
http://www.vanderbilt.edu

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>